ProQR Therapeutics (PRQR) Q1 2024 Earnings
PRQR·Reported May 9, 2024·Before market open
ProQR Therapeutics reported Q1 2024 revenue of $4.8M, beat analyst consensus of $2.8M by $2.0M. Diluted EPS came in at $-0.10, beat the $-0.12 consensus by $0.02.
Revenue
$4.8Mbeat by $2.0M
Consensus: $2.8MDiluted EPS
$-0.10beat by $0.02
Consensus: $-0.12
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2024 Earnings FAQ
Common questions about ProQR Therapeutics's Q1 2024 earnings report.
ProQR Therapeutics (PRQR) reported Q1 2024 earnings on May 9, 2024 before market open.
ProQR Therapeutics reported revenue of $4.8M and diluted EPS of $-0.10 for Q1 2024.
Revenue beat the consensus estimate of $2.8M by $2.0M. EPS beat the consensus estimate of $-0.12 by $0.02.